![Monique Létourneau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Monique Létourneau
Director/Board Member at Oxfam-Québec
Monique Létourneau active positions
Companies | Position | Start | End |
---|---|---|---|
Oxfam-Québec
![]() Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty. | Director/Board Member | - | - |
Commerce Équitable Oxfam-québec | Corporate Officer/Principal | - | - |
Career history of Monique Létourneau
Former positions of Monique Létourneau
Companies | Position | Start | End |
---|---|---|---|
Financial Executives International Canada
![]() Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Financial Executives International Canada operates as a professional membership organization. The company is headquartered in Toronto, Canada. | Director/Board Member | - | 2014-06-03 |
Génome Québec, Inc.
![]() Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | 2011-07-20 | 2013-06-18 |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Director of Finance/CFO | 2000-12-31 | 2009-07-28 |
Procyon Biopharma, Inc.
![]() Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | Director of Finance/CFO | - | 2006-03-02 |
Training of Monique Létourneau
HEC Montréal | Graduate Degree |
Statistics
International
Canada | 8 |
Operational
Director/Board Member | 3 |
Director of Finance/CFO | 2 |
Graduate Degree | 1 |
Sectoral
Commercial Services | 5 |
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
Procyon Biopharma, Inc.
![]() Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | Commercial Services |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Oxfam-Québec
![]() Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty. | Commercial Services |
Financial Executives International Canada
![]() Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Financial Executives International Canada operates as a professional membership organization. The company is headquartered in Toronto, Canada. | Commercial Services |
Commerce Équitable Oxfam-québec | |
Génome Québec, Inc.
![]() Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
- Stock Market
- Insiders
- Monique Létourneau
- Experience